| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,508 | 4,818 | 5,979 | 31,465 | | Cost of Revenue |
-
|
-
|
-
| (51,641) | | | Gross Profit | 4,508 | 4,818 | 5,979 | 83,106 | | | Operating Expenses | | Research Development | 7,095 | 11,421 | 19,271 | 68,077 | | Selling General and Administrative | 5,923 | 5,164 | 7,829 | 7,018 | | Non Recurring | 1,350 |
-
| 1,936 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,860) | (11,767) | (23,057) | 8,011 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 379 | 66 | 113 | 526 | | Earnings Before Interest And Taxes | (9,481) | (11,701) | (22,944) | 8,537 | | Interest Expense | 2,712 | 2,718 | 1,947 | 2,119 | | Income Before Tax | (12,193) | (14,419) | (24,891) | 6,418 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,193) | (14,419) | (24,891) | 6,418 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,193) | (14,419) | (24,891) | 6,418 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,193) | ($14,419) | ($24,891) | $6,418 |
|
0.51% Nasdaq 
0.01 (0.31%) 
Income Statement
